These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 19663110)
21. Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study. Wind BS; Kroon MW; Meesters AA; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Bos JD; Wolkerstorfer A Lasers Surg Med; 2010 Sep; 42(7):607-12. PubMed ID: 20806385 [TBL] [Abstract][Full Text] [Related]
22. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study. Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227 [TBL] [Abstract][Full Text] [Related]
23. Skin-lightening effects of a new face care product in patients with melasma. Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815 [TBL] [Abstract][Full Text] [Related]
24. Topical 10% zinc sulfate solution for treatment of melasma. Sharquie KE; Al-Mashhadani SA; Salman HA Dermatol Surg; 2008 Oct; 34(10):1346-9. PubMed ID: 18616534 [TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months. Bruce S J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930 [TBL] [Abstract][Full Text] [Related]
27. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients. Sarkar R; Bhalla M; Kanwar AJ Dermatology; 2002; 205(3):249-54. PubMed ID: 12399672 [TBL] [Abstract][Full Text] [Related]
28. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227 [TBL] [Abstract][Full Text] [Related]
29. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma. Arrowitz C; Schoelermann AM; Mann T; Jiang LI; Weber T; Kolbe L J Invest Dermatol; 2019 Aug; 139(8):1691-1698.e6. PubMed ID: 30825454 [TBL] [Abstract][Full Text] [Related]
30. Treatment of melasma using fractional photothermolysis: a report of eight cases with long-term follow-up. Katz TM; Glaich AS; Goldberg LH; Firoz BF; Dai T; Friedman PM Dermatol Surg; 2010 Aug; 36(8):1273-80. PubMed ID: 20666816 [TBL] [Abstract][Full Text] [Related]
31. Is topical zinc effective in the treatment of melasma? A double-blind randomized comparative study. Yousefi A; Khani Khoozani Z; Zakerzadeh Forooshani S; Omrani N; Moini AM; Eskandari Y Dermatol Surg; 2014 Jan; 40(1):33-7. PubMed ID: 24237751 [TBL] [Abstract][Full Text] [Related]
32. Community-based trial of a triple-combination agent for the treatment of facial melasma. Grimes P; Kelly AP; Torok H; Willis I Cutis; 2006 Mar; 77(3):177-84. PubMed ID: 16610738 [TBL] [Abstract][Full Text] [Related]
33. A randomized controlled pilot study of a proprietary combination versus sunscreen in melasma maintenance. Chatterjee M; Neema S; Rajput GR Indian J Dermatol Venereol Leprol; 2021; 88(1):51-58. PubMed ID: 34379946 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma. Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063 [TBL] [Abstract][Full Text] [Related]
35. Facial skin-lightening benefits of the tetrapeptide Pro-Lys-Glu-Lys on subjects with skin types V-VI living in South Africa. Farwick M; Maczkiewitz U; Lersch P; Summers B; Rawlings AV J Cosmet Dermatol; 2011 Sep; 10(3):217-23. PubMed ID: 21896134 [TBL] [Abstract][Full Text] [Related]
36. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Espinal-Perez LE; Moncada B; Castanedo-Cazares JP Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189 [TBL] [Abstract][Full Text] [Related]
38. A double-blind controlled study of a nonhydroquinone bleaching cream in the treatment of melasma. Levy JL; Pons F; Agopian L; Besson R J Cosmet Dermatol; 2005 Dec; 4(4):272-6. PubMed ID: 17168876 [TBL] [Abstract][Full Text] [Related]
39. [Double-blind clinical study of the treatment of melasma with azelaic acid versus hydroquinone]. Piquero Martín J; Rothe de Arocha J; Beniamini Loker D Med Cutan Ibero Lat Am; 1988; 16(6):511-4. PubMed ID: 3073279 [TBL] [Abstract][Full Text] [Related]